GU Cancer Clinical Trials

DISCLAIMER: All content found on cua.org is provided for information and education purposes. The medical information and clinical trials information is not intended to substitute for the advice of a physician, nor is it intended to provide legal advice. You should always consult your doctor for specific information on personal health matters, or other relevant professionals to ensure that your own circumstances are considered.

The CUA is not responsible in any manner for direct, indirect, special or consequential damages caused and/or arising from your use of cua.org.

Subspecialty
Bladder | BC, NS, ON, QC | Not yet recruiting
CANUCK-01
A Canadian Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer
Dr. Paul Toren
Start Date: August 30, 2023

NCT #: NCT06018116

SPONSORCHU de Quebec-Universite Laval in Collaboration with Cancer Research Society

INFO: https://classic.clinicaltrials.gov/ct2/show/NCT06018116

CONTACTPaul.Toren@crchudequebec.ulaval.ca (CHUQ)  

Other Canadian Centres:

BCCA-Vancouver Cancer Centre (Vancouver)

QEII Health Sciences Centre (Halifax)

London Regional Cancer Program (London)

University Health Network (Toronto)

McGill University Health Centre (Montreal)

Renal | ON | Not yet recruiting
INCB 99280-205
Interventional Study of INCB 99280 With Ipilimumab in Participants With Select Solid Tumors
Incyte Corporation
Start Date: August 29, 2023

NCT #: NCT05909995

SPONSOR: Incyte Corporation

INFO: https://clinicaltrials.gov/study/NCT05909995

CONTACT: 1-855-463-3464

medinfo@incyte.com

Other Canadian Centres:

Princess Margaret Cancer Centre (Toronto)

Renal | ON | Recruiting
AQuOS-ll
Assessment of Quality of Life and Outcomes in Patients With Primary Renal Cell Carcinoma Treated With SBRT (AQuOS-II)
Dr. William Chu
Start Date: January 10, 2023

NCT #: NCT05023265

SPONSOR: Sunnybrook Health Sciences Centre

INFO: https://clinicaltrials.gov/study/NCT05023265?term=NCT05023265&rank=1

CONTACT:  

1. Dr. William Chu (Sunnybrook) 
Contact Coordinator: Murtuza Saifuddin: murtuza.saifuddin@sunnybrook.ca
2. Dr. Anand Swaminath (Hamilton)
Contact Coordinator: Carmela Oliverio: coliveri@HHSC.CA
3. Dr. Howard Pai (Victoria)
Contact Coordinator:  Emily White: emil.white@bccancer.bc.ca
4. Dr. Darin GoPaul (Kitchener)
Contact Coordinator: Atif Siddiqui: Atif.Siddiqui@grhosp.on.ca
5. Dr. Lucas Mendez (London)
Contact Coordinator:  Kes.Sebborn@lhsc.on.ca
6. Dr. Mark Richard Niglas (Oshawa)
Contact Coordinator: Mary Tannourji: mtannourji@lh.ca 

OTHER CANADIAN CENTRES:

1. Hamilton Health Sciences/Juravinski Cancer Centre
2. BC Cancer Agency (Victoria)
3. Health Sciences North (Sudbury)
4. Grant River (Kitchener)
5. London Health Sciences Centre
6. Lakeridge Health, RS McLaughlin Durham Reg Cancer Centre (Oshawa)

Prostate | ON | Recruiting
MIDAS-Prostate
Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy for Prostate Cancer
Dr. Srinivas Raman
Start Date: November 1, 2022

NCT #: NCT05328505

SPONSOR: University Health Network, Toronto

INFOhttps://www.clinicaltrials.gov/ct2/show/NCT05328505

CONTACT: 416-946-2320 

Renal | ON | Recruiting
CKFA115A12101
A Study of Safety and Efficacy of KFA115 Alone and KFA115 in Combination With Tislelizumab in Patients With Select Advanced Cancers
Novartis Pharmaceuticals
Start Date: October 26, 2022

NCT #: NCT05544929

SPONSOR: Novartis Pharmaceuticals

INFO: https://clinicaltrials.gov/study/NCT05544929

CONTACT1-888-669-6682                                        

novartis.email@novartis.com

Other Canadian Centres:

Princess Margaret Cancer Centre (Toronto)

Prostate | ON | Recruiting
MOB-RT
Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer (MOB-RT)
Dr. Rachel Glicksman
Start Date: July 18, 2022

NCT #: NCT05313815

SPONSOR: University Health Network, Toronto

INFO: https://clinicaltrials.gov/ct2/show/NCT05313815

CONTACT:  416-946-4483

Bladder | ON | Recruiting
D9450C00001
A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours
AstraZeneca
Start Date: July 7, 2022

NCT #: NCT05397171

SPONSOR: AstraZeneca

INFOhttps://clinicaltrials.gov/ct2/show/NCT05397171?recrs=abf&cond=Urothelial+Carcinoma&cntry=CA&draw=2&rank=15

CONTACT:  1-877-240-9479

OTHER CANADIAN CENTRES:

1. The Ottawa Hospital

2. Mount Sinai Hospital (Toronto)

Renal | ON | Recruiting
MOHCCN-O
Marathon of Hope Cancer Centres Network Study for Ontario
University Health Network. Collaboration with PMH, OICR and Terry Fox Research Institute
Start Date: June 13, 2022

NCT #: NCT05403177

SPONSOR:  University Health Network

INFOhttps://clinicaltrials.gov/ct2/show/NCT05403177?recrs=abf&cond=Renal+Cell+Carcinoma&cntry=CA&draw=2&rank=17

CONTACT: 

Sophie Cooke, MSc: 416-946-4501 x 3486

OTHER CANADIAN CENTRES:

Princess Margaret Cancer Centre (Toronto)               

Bladder | ON | Recruiting, by invitation only
ROSY-D
Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab (ROSY-D)
Start Date: April 19, 2022

NCT #: NCT05303532

SPONSOR: AstraZeneca

INFO:  https://clinicaltrials.gov/ct2/show/NCT05303532?recrs=abf&cond=Urothelial+Carcinoma&cntry=CA&draw=2&rank=5

CONTACT: Southlake Regional Health Centre (Newmarket): 905-895-4521 (Canadian Site)

OTHER CANADIAN CENTRES:

1. Southlake Regional Health Centre (Newmarket): 905-895-4521

 

Bladder | QC | Recruiting
BicaBCa
A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer (BicaBCa)
Dr. Paul Toren
Start Date: April 14, 2022

NCT #: NCT05327647

SPONSORCHU de Quebec-Universite Laval in Collaboration with Canadian Institute of Health Research (CIHR)

INFOhttps://classic.clinicaltrials.gov/ct2/show/NCT05327647

CONTACT

Paul.Toren@crchudequebec.ulaval.ca (CHUQ)     418-525-4444 ext 17064                                            

wassim.kassouf.med@ssss.gouv.qc.ca                  514-934-8246                                                                        

jean-baptiste.lattouf.med@ssss.gouv.qc.ca

Other Canadian Centres:

CHU de Québec-Université (Laval): Dr. P. Toren                                    

McGill University Health Centre (Montreal: Dr.Wassim Kassouf                            

Centre Hospitalier de l'Université De Montréal (CHUM): Dr. Jean-Baptiste Lattouf